Arman Financial consol PAT ₹51.5 Cr (+14% QoQ); MFI recovery holds into 2nd quarter
PAT +543.98% YoY · revenue +47.38% · margins expanding
₹234.64 Cr
+47.38% YoY
₹51.48 Cr
+543.98% YoY
21.94%
+16.9pp YoY
₹48.94
Arman Financial Services' consolidated PAT came in at ₹51.48 Cr on revenue of ₹234.64 Cr for Q2 FY27, up 14% and 16% QoQ respectively, and up 544% and 47% YoY. The YoY PAT jump is a base-effect optic, not organic growth of that scale: Q2 FY26 was a stress-quarter trough (₹7.99 Cr PAT, 5.02% NPM) when MFI-sector credit costs were elevated across the industry. The more informative read is sequential — this is the second straight quarter of recovery after Q1 FY27's loss-to-profit turnaround, with NPM holding near 22% (21.94% now vs 22.38% in Q1) rather than re-compressing.
Q2 FY-2027 vs prior quarters
The margin bridge is almost entirely an impairment story: consolidated impairment losses on financial assets fell to ₹25.85 Cr this quarter from ₹38.27 Cr a year ago, even as the loan book grew (gross loans ₹2,610.49 Cr vs ₹2,213.47 Cr at FY26-end), while finance cost and employee cost scaled roughly in line with the larger book. The consolidated-vs-standalone divergence is material and worth flagging explicitly: parent (standalone) PAT grew a more modest 95% YoY to ₹17.37 Cr on ₹67.90 Cr revenue (NPM 25.58%), while wholly-owned subsidiary Namra Finance — the MFI arm — contributed ₹33.82 Cr PAT on ₹167.78 Cr revenue, nearly double the parent's profit. Consolidated growth is thus led by the subsidiary's sharper normalization off last year's stress, not the parent NBFC.
The stock went into the print at ₹1,529.2, down 12.9% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Consolidated basic EPS ₹48.94 vs ₹42.96 in Q1 FY27 and ₹7.62 a year ago
Target opex ratio of 7% by FY27 end (currently 8%, was 9% prior Q). Credit cost expected 3–3.5% going forward including CGFMU. Infrastructure supports ₹750 Cr quarterly disbursements. No formal PAT/margin targets stated.
On guidance: management's prior concall targets (opex ratio to 7% by FY27-end from 8% currently, credit cost of 3–3.5% including CGFMU, ₹750 Cr quarterly disbursement capacity) are not independently verifiable from this filing, which doesn't disclose AUM or disbursement figures — flagged as a gap rather than assumed. As a rough cross-check, this quarter's impairment charge annualizes to roughly 4% of the average loan book, which would sit above the guided 3–3.5% credit-cost band, though the comparison is approximate given it uses period-end loan book rather than average AUM. No formal PAT/margin target was given, so there is no miss/beat to call on the bottom line itself. On street expectations, no Q2 FY27-specific consensus preview was found; the only forward reference located was a full-year FY27 analyst PAT-growth expectation of 15–20% tied to a ₹2,000 price target, which is a different time horizon and cannot be graded against this single quarter. We have no management press-release text for this result to cross-check against the numbers.
W1
Credit cost run-rate: this quarter's ₹25.85 Cr impairment charge annualizes to roughly 4% of the average loan book — watch whether it moves into management's guided 3–3.5% band (incl. CGFMU)
W2
Opex ratio glide path to management's 7% FY27-end target (from 8% currently) — not disclosed in this filing; confirm via the next investor presentation/concall
W3
Stage III ratio (2.73% gross / 0.92% net this quarter) — watch for further improvement as the post-stress MFI book seasons
Informational and educational content only. Not investment advice.